BioMatNet Logo
home BioMatNet ITEM update contact BioMatNet register
FP7 Information
Database of Websites
Crops
Products
All Projects
FP7 Projects
FP6 Projects
FP5 Projects
FAIR Projects
Publications
Legislation
Partner Search
[BioMatNet Database - FP5 Quality of Life Programme] FP5
Theme 1 - Key Action 3 - The "Cell Factory"
Website: www.cordis.lu/fp5/home.html




To find similar Items, click on a keyword below:
Background Information



Objectives and deliverables

The socio-economic objective of this key action is the integration of innovative research and technologies with the exploitation of advances made in life sciences and technologies, particularly in the fields of health, environment, food, agriculture, agro-industries and high value-added products, by Community's enterprises and by the public sector. The problem solving approach of this key action will give particular attention to strengthening European industrial competitiveness by improving the potential for creation of small research-based biotechnology firms and entrepreneurial initiatives. These knowledge-based new industries correspond to a reservoir of industrial competitiveness, scientific and technological innovation, opportunities for investors, and jobs creation, which is still under exploited in Europe. The challenge is to integrate the whole range of innovation, from advanced research, through technological development up to demonstration, providing an environment in which scientific results could rapidly be exploited and transformed into products and processes of interest to the society. This key action will therefore mobilise the necessary operators (scientists, industrialists, venture capitalists, consumer and patient's associations) to address the following objectives in a coordinated and convergent way:

Towards the anticipated deliverable consisting in developing established bioindustries, triggering the creation and sustaining the growth rate of new biotech research-based industries, the European players should be mobilised to seize those opportunities in priority areas that include:

PRIORITIES FOR THE 1999 CALLS

The projects to be supported must address the link between the ability to discover and the ability to exploit, through focusing on the mobilisation of players from research, industry, and finance sectors. They are expected to combine, as appropriate, innovative technologies with bio-industries, SMEs and/or entrepreneurial initiatives, in order to both develop RTD advances and exploit them to deliver bio-products and processes. An important message to the applicants is that this key action does not exclude basic research, nor focus only on applied research, but should mobilise whatever scientific excellence, innovative technologies and convincing exploitation strategies are needed for reaching the socio-economic objectives and address the problem-solving approach of this key action, as stated in the "Objectives and deliverables". In view of those requirements, the projects can address a wide spectrum of targets, provided they focus on the above requirements and on the objectives of the key action. Consequently, the following RTD priorities are illustrative examples which are not supposed to cover all potential RTD activities to be implemented in this key action, and leave room for innovative ideas from the applicants.

In particular

Key action 3 area 1 includes:

3.1.2. New and improved technologies for biological productions. Aspects for consideration: improved technologies for the production of health related substances, e.g. novel and safe animal cells-based production systems for pharmaceutical substances including vaccine production, novel plant-based production systems for pharmaceutical substances.

Key action 3 Area 2. includes:

Energy - efficient bioremediation and waste biotreatment processes, covering new bioprocesses for preventing industrial pollution, treating, upgrading, and/or recycling of biological wastes and industrial by-products. Aspects for consideration includes processes for preventing pollution at the source, and the consumption of energy and raw material. Emphasis will be given to develop new enzyme and industrial process technologies exploiting modern biotechnology, e.g. the development of novel biocatalysts or the design of micro-organisms to carry out specific tasks. In addition, methodologies should be developed for biotechnological processes and products and methods for waste water treatment and water recycling.

3.2.4. Biodiversity and ecological dynamics of natural and introduced populations includes, within the "Aspects for consideration", methods and approaches to assessing the impacts of novel uses of biodiversity, e.g. biofertilisers and biopesticides. Another section covers transgenic plants resistant to phytopathogenic agents or plants used for novel industrial uses.

3.2.5. Development of methods and strategies to ensure the safety of new biomolecules or bioprocesses, and for the identification of recombinant organisms and their residues in the environment and their impact on human and animal health.

3.3. New biological and biotechnological processes and products from cell factories, Exploiting the cellular and molecular characteristics of organisms and the use of biological systems as tools in the development of new products and technologies. Studies will be at the level of molecules (e.g. biomolecules self assembly), the coupling of molecules and cells to surfaces (e.g. control of interactions between proteins and cells and surfaces) and the functional structures (e.g. material processing technologies for nanofabrication).

3.3.2. High value-added products and processes involving/derived from microorganisms, plants and animals, includes in the "Aspects for consideration", development of more efficient fermentation, biotransformation, and downstream processing as well as engineering of the pathways of primary and secondary metabolites of plants of economic importance including the cellular and organ optimisation of compounds.

3.3.4. Identification and sustainable use of metabolic and genetic diversity as a source of new valuable products, includes in "Aspects for consideration", new or improved methods for screening of marine and terrestrial organisms and molecular characterisation of wild and domesticated populations, including unculturable microorganisms, to identify useful products and genes for transgenic production systems.

See also:
Work Programme
Theme 1 Key action 5. - Sustainable agriculture, fisheries and forestry, and integrated development for rural areas
Theme 1 Key action 5. Area 2 - biological materials for non-food uses
Theme 1 Key action 5. Area 3 - Forestry and the integrated forestry-wood chain
Theme 1 Key action 5. Area 1- New and sustainable systems of production





Click to display FP5 - Fifth Framework Programme (1998-2002): Quality of Life - 3. The Cell Factory Item:

FP5 - Fifth Framework Programme (1998-2002)

© Copyright 2006    Policy Statements    
Updated by CPL Press: 24/09/2007 - biomatnet@biomatnet.org

 


with Google

News

Global News ...

View All News Items...

Events

Events Diary ...

 
BioMatNet Database Sixth Framework Programme (FP6) Research Home Page